A Randomised, Double Blind, Three-period Cross-over Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With Type 1 Diabetes Mellitus (T1DM)
Phase of Trial: Phase I/II
Latest Information Update: 27 Oct 2016
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Adocia
- 27 Oct 2016 Primary endpoint has been met. (BG1h (To compare the effect of HinsBet and Humulin on the postmeal glycemic control one hour after the meal)), according to an Adocia media release.
- 27 Oct 2016 According to an Adocia media release, the company intends to submit the results from the study for presentation at a major diabetes-related conference.
- 27 Oct 2016 Top-line results published in an Adocia media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History